Michael Conick Hanley
Directeur des opérations chez ALTO NEUROSCIENCE, INC.
Fortune : 50 608 $ au 31/05/2024
Profil
Michael Conick Hanley's current job is Chief Operating Officer at Alto Neuroscience, Inc. His former jobs include Chief Business Officer at Spyre Therapeutics, Inc., Group Vice President-Marketing at Horizon Therapeutics Plc, and Chief Commercial Officer & Vice President at Esteve Pharmaceuticals S.A.
He completed his undergraduate degree at Notre Dame University and holds an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SPYRE THERAPEUTICS, INC
0,00% | 23/02/2023 | 1 448 ( 0,00% ) | 50 608 $ | 31/05/2024 |
ALTO NEUROSCIENCE, INC.
-.--% | 20/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Michael Conick Hanley
| Sociétés | Poste | Début |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Directeur des opérations | 20/05/2024 |
Anciens postes connus de Michael Conick Hanley
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 14/04/2023 |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 01/09/2019 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Sales & Marketing | 01/06/2017 |
Formation de Michael Conick Hanley
| Kellogg School of Management | Masters Business Admin |
| Notre Dame University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| ALTO NEUROSCIENCE, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
